Lifecore Biomedical, Inc. (LFCR)
6.445
-0.08
(-1.15%)
USD |
NASDAQ |
Oct 06, 16:00
6.45
0.00 (0.00%)
After-Hours: 18:50
Lifecore Biomedical Cash from Operations (Quarterly) : -2.189M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.189M |
| March 31, 2026 | 4.70M |
| December 31, 2025 | |
| September 30, 2025 | |
| May 31, 2025 | 5.347M |
| February 28, 2025 | 1.20M |
| November 30, 2024 | -6.11M |
| August 31, 2024 | -0.613M |
| May 31, 2024 | 8.764M |
| February 29, 2024 | -1.658M |
| November 30, 2023 | 1.006M |
| August 31, 2023 | -8.329M |
| May 31, 2023 | 1.407M |
| February 28, 2023 | -15.39M |
| November 30, 2022 | -2.353M |
| August 31, 2022 | -1.101M |
| May 31, 2022 | -0.548M |
| February 28, 2022 | -17.74M |
| November 30, 2021 | -5.005M |
| August 31, 2021 | 0.699M |
| May 31, 2021 | 14.03M |
| February 28, 2021 | -16.23M |
| November 30, 2020 | 0.71M |
| August 31, 2020 | 16.51M |
| May 31, 2020 | -12.70M |
| Date | Value |
|---|---|
| February 29, 2020 | 10.58M |
| November 30, 2019 | -9.483M |
| August 31, 2019 | -5.439M |
| May 31, 2019 | -1.429M |
| February 28, 2019 | 12.65M |
| November 30, 2018 | 2.617M |
| August 31, 2018 | 2.186M |
| May 31, 2018 | -0.521M |
| February 28, 2018 | 13.96M |
| November 30, 2017 | 2.886M |
| August 31, 2017 | 3.45M |
| May 31, 2017 | 6.246M |
| February 28, 2017 | 17.65M |
| November 30, 2016 | -0.94M |
| August 31, 2016 | 6.467M |
| May 31, 2016 | 15.24M |
| February 29, 2016 | 4.33M |
| November 30, 2015 | 4.031M |
| August 31, 2015 | -1.839M |
| May 31, 2015 | 12.78M |
| February 28, 2015 | 10.03M |
| November 30, 2014 | -0.593M |
| August 31, 2014 | 3.943M |
| May 31, 2014 | 7.211M |
| February 28, 2014 | 9.541M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Codexis, Inc. | -9.643M |
| Quanterix Corp. | -5.119M |
| Frontage Holdings Corp. | -- |
| Repligen Corp. | 32.77M |
| Bio-Techne Corp. | 95.42M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.513M |
| Cash from Financing (Quarterly) | -0.852M |
| Free Cash Flow Per Share (Quarterly) | -0.0719 |
| Free Cash Flow to Equity (Quarterly) | -8.936M |
| Free Cash Flow to Firm (Quarterly) | 5.078M |
| Free Cash Flow Yield | -5.67% |